skip to Global Navigation Bar skip to main content

homeHome > About Us > Press Release > News


News Content
Daewoong Pharmaceutical Sets Standard for Global Drug Safety Reporting with Oracle
Date 2019-01-17 Hit 737
News List
Prev Daewoong’s ‘NABOTA’ submitted the form to change clinical test plans in China.
Next Daewoong Pharmaceutical’s ‘NABOTA’ becomes the first Korea-made Botulinum Toxin to obtain US FDA approval